Implementing scale dependencies into computational bioreactor models to facilitate predictions of protein glycosylation in different environments

This project will deliver an interoperable simulation platform integrating spatially resolved CFD flow fields, cell kinetics, and mechanistic models of intracellular glycosylation.
Categories
Drug substance
Process control
Data

Industry Need

Although significant progress has been made in modeling glycosylation at small scales, scaling up to production bioreactors introduces complex gradients in nutrients, oxygen, pH, and metabolite concentrations that affect cellular performance, ultimately impacting product properties including glycosylation. This project addresses a critical need in upstream bioprocess modeling: predicting the impact of hydrodynamic heterogeneity on glycosylation outcomes during CHO based protein production for different scales and bioreactor configurations.

Approach

This proposal brings together researchers in mammalian hydrodynamics (Jeffrey Chalmers, Ohio State) and systems biology of glycosylation (Michael Betenbaugh, Johns Hopkins) to deliver an interoperable simulation platform integrating spatially resolved CFD flow fields, cell kinetics, and mechanistic models of intracellular glycosylation.

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

The Ohio State University

The Ohio State University

Participating Organizations

AstraZeneca

AstraZeneca

Boehringer Ingelheim

Boehringer Ingelheim

Bristol-Myers Squibb

Bristol-Myers Squibb

EMD Millipore Corporation

EMD Millipore Corporation

Federal Stakeholder:  National Institute of Standards and Technology

Federal Stakeholder: National Institute of Standards and Technology

Johns Hopkins University

Johns Hopkins University

Pfizer, Inc.

Pfizer, Inc.

Sanofi

Sanofi